The latest update is out from Orasure Technologies ( (OSUR) ).
On February 25, 2025, OraSure Technologies announced its financial results for the fourth quarter of 2024, reporting a 10% growth in core revenue despite a 51% decline in total net revenues compared to the previous year. The company highlighted its strategic transformation and acquisition of Sherlock Biosciences as key drivers for future growth, aiming to expand its product portfolio and customer base while addressing uncertainties related to government funding.
More about Orasure Technologies
OraSure Technologies, Inc. is a leader in point-of-need and home diagnostic tests and sample management solutions.
YTD Price Performance: 12.71%
Average Trading Volume: 878,056
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $297.6M
See more insights into OSUR stock on TipRanks’ Stock Analysis page.